U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06917872) titled 'A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood' on April 07.
Brief Summary: The main objective of this trial is to investigate the effect of erythromycin, a moderate CYP3A4 inhibitor on the pharmacokinetics of BI 1291583 at steady state.
Study Start Date: April 29
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: BI 1291583
BI 1291583
DRUG: erythromycin
erythromycin
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Published by HT Digital Content Services with permission from Health Daily Digest....